KPV is a tripeptide studied for gut barrier support, anti-inflammatory activity, and GI mucosal protection. Physician-reviewed. Prescription required.
KPV is a small peptide fragment derived from Alpha-Melanocyte-Stimulating Hormone. It retains the anti-inflammatory and immunomodulatory effects of α-MSH but without most of the pigment-related activity. KPV primarily acts through suppression of inflammatory signaling pathways, modulation of immune responses, and enhancement of epithelial barrier repair.
Individual outcomes may differ. This protocol is not intended to diagnose, treat, cure, or prevent any disease.
| Mechanism | Biological Effect |
|---|---|
| NF-κB inhibition | Reduced inflammatory cytokines |
| Melanocortin pathway modulation | Immune regulation |
| Antimicrobial peptide activity | Direct pathogen suppression |
| Intestinal epithelial protection | Reduced gut inflammation |
| Immune cell modulation | Lower neutrophil/macrophage activation |
Your physician will determine eligibility based on your complete health intake. The following profiles are commonly associated with KPV protocol candidates in clinical practice:
GI Inflammation
Individuals with inflammatory bowel conditions where GI mucosal support may be clinically appropriate.
Gut Barrier Support
Individuals with gut permeability concerns under physician supervision.
Combination Recovery
Patients combining KPV with BPC-157 in a physician-reviewed GI recovery protocol.
Immune Modulation
Individuals with immune dysregulation where KPV's melanocortin pathway activity may be relevant.
Determine your candidacy
A physician will review your intake and make eligibility determination within 24–48 hours.
All outcome language below reflects what has been observed in clinical and preclinical settings. Individual outcomes may differ significantly. These are not guarantees.
Dosing is determined individually by your assigned physician. The following represents typical ranges discussed in clinical literature. Do not self-administer or adjust dosing without physician guidance.
Typical Range
500 mcg–2 mg/day
Administration
Oral or subcutaneous
Duration
4–12 weeks (physician-determined)
Frequency
Once daily (physician-determined)
These ranges are indicative only. Your physician will prescribe the specific dose and schedule appropriate for your clinical profile.
Physician consultation — Virtual intake review and protocol consultation with your assigned NP/MD
Valid prescription — Issued by your attending physician upon protocol approval
Pharmacy-dispensed compound — Dispensed by our licensed 503A compounding pharmacy partner
Follow-up check-in — Physician review at protocol midpoint; reorder pathway established
Your physician will review your complete health history before determining eligibility. The following are commonly reviewed clinical considerations.
Begin your KPV protocol.
Complete your intake. Physician review within 24–48 hours.
Physician-reviewed. Pharmacy-dispensed. Prescription required before any order is fulfilled.
Prescription required. Results may vary. Individual outcomes may differ.
KPV (Lys-Pro-Val) is an anti-inflammatory peptide derived from alpha-MSH. It is used for gut inflammation, skin conditions, wound healing, and as an anti-inflammatory adjunct to recovery protocols.
Yes. KPV is particularly effective for inflammatory bowel conditions including Crohn's disease and ulcerative colitis. It acts locally in the gut to suppress inflammatory cytokines and promote mucosal healing.
Verum Health offers KPV as both an injectable and oral capsule. For gut conditions, oral KPV provides targeted local delivery to the GI tract. Injectable KPV is used for systemic anti-inflammatory effects.
Yes. KPV + BPC-157 is a popular gut healing stack. They work via complementary mechanisms — BPC-157 promotes tissue repair while KPV suppresses inflammation at the mucosal level.